Raiffeisen Bank International AG Buys Shares of 3,172 Axon Enterprise, Inc. (NASDAQ:AXON)

Raiffeisen Bank International AG bought a new position in shares of Axon Enterprise, Inc. (NASDAQ:AXON - Free Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 3,172 shares of the biotechnology company's stock, valued at approximately $1,917,000.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. New Wave Wealth Advisors LLC bought a new stake in shares of Axon Enterprise during the 4th quarter valued at about $40,000. Y.D. More Investments Ltd purchased a new stake in Axon Enterprise in the fourth quarter valued at approximately $45,000. Stonebridge Financial Group LLC bought a new stake in Axon Enterprise during the fourth quarter valued at approximately $53,000. GPS Wealth Strategies Group LLC lifted its position in Axon Enterprise by 74.1% during the fourth quarter. GPS Wealth Strategies Group LLC now owns 94 shares of the biotechnology company's stock valued at $56,000 after purchasing an additional 40 shares during the last quarter. Finally, Berbice Capital Management LLC bought a new stake in Axon Enterprise during the fourth quarter valued at approximately $59,000. Hedge funds and other institutional investors own 79.08% of the company's stock.

Analysts Set New Price Targets

Several brokerages have issued reports on AXON. Northcoast Research lowered shares of Axon Enterprise from a "buy" rating to a "neutral" rating in a research report on Wednesday, February 19th. The Goldman Sachs Group increased their target price on Axon Enterprise from $730.00 to $830.00 and gave the company a "buy" rating in a research note on Wednesday, May 14th. Barclays lifted their price objective on Axon Enterprise from $726.00 to $735.00 and gave the stock an "overweight" rating in a research report on Friday, May 9th. JMP Securities reiterated an "outperform" rating on shares of Axon Enterprise in a report on Tuesday, February 4th. Finally, Craig Hallum cut shares of Axon Enterprise from a "buy" rating to a "cautious" rating in a research report on Monday, March 10th. One equities research analyst has rated the stock with a sell rating, one has assigned a hold rating and ten have given a buy rating to the stock. According to MarketBeat.com, the company has a consensus rating of "Moderate Buy" and an average price target of $652.73.

Axon Enterprise Stock Up 0.1%

Shares of NASDAQ AXON traded up $0.43 during mid-day trading on Tuesday, hitting $742.75. 383,468 shares of the stock traded hands, compared to its average volume of 751,632. The company has a debt-to-equity ratio of 0.32, a quick ratio of 2.63 and a current ratio of 2.96. Axon Enterprise, Inc. has a 52 week low of $273.52 and a 52 week high of $744.51. The company has a market cap of $57.82 billion, a price-to-earnings ratio of 191.93, a PEG ratio of 5.17 and a beta of 1.24. The stock has a fifty day moving average price of $588.30 and a 200-day moving average price of $597.92.

Axon Enterprise (NASDAQ:AXON - Get Free Report) last announced its earnings results on Wednesday, May 7th. The biotechnology company reported $1.41 earnings per share for the quarter, beating analysts' consensus estimates of $1.34 by $0.07. Axon Enterprise had a net margin of 15.37% and a return on equity of 7.50%. The business had revenue of $603.63 million during the quarter, compared to the consensus estimate of $585.67 million. During the same quarter last year, the firm earned $1.15 earnings per share. The business's revenue for the quarter was up 31.3% on a year-over-year basis. Research analysts anticipate that Axon Enterprise, Inc. will post 5.8 EPS for the current year.

Insiders Place Their Bets

In other Axon Enterprise news, Director Caitlin Elizabeth Kalinowski sold 1,300 shares of Axon Enterprise stock in a transaction dated Monday, May 19th. The shares were sold at an average price of $738.84, for a total value of $960,492.00. Following the completion of the transaction, the director now directly owns 4,829 shares of the company's stock, valued at approximately $3,567,858.36. The trade was a 21.21% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, CEO Patrick W. Smith sold 10,000 shares of the stock in a transaction that occurred on Monday, April 21st. The shares were sold at an average price of $540.99, for a total transaction of $5,409,900.00. Following the sale, the chief executive officer now owns 3,063,982 shares in the company, valued at approximately $1,657,583,622.18. The trade was a 0.33% decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders have sold 25,064 shares of company stock valued at $15,817,127. 4.40% of the stock is currently owned by corporate insiders.

About Axon Enterprise

Axon Enterprise, Inc develops, manufactures, and sells conducted energy devices (CEDs) under the TASER brand in the United States and internationally. It operates through two segments, Software and Sensors, and TASER. The company also offers hardware and cloud-based software solutions that enable law enforcement to capture, securely store, manage, share, and analyze video and other digital evidence.